Endpoints News

GHO Capital, CBC Group to merge		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T Wed Th F

20 May, 2026

LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.

news

Parabilis reveals IPO plans the day after Regeneron deal as listings heat up

GHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investor

Exclusive: Acceleron leaders and Westlake jumpstart new IPF biotech

May 20

11:00 am ET

Application of Simple Western to analysis of antibody target affinity and specificity

in case you missed it

Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study

Wave aims for monthly dosing with RNA editing treatment for AATD

News Briefing

Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug

BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test

This U.S. doctor went to Congo to heal others. Then Ebola hit his hospital.

GHO Capital and CBC Group are to merge, forming what they say would be the largest healthcare specialist investment company in the world with over $21 billion in assets under management. For context, OrbiMed has around $20 billion and Blackstone Life Sciences has about $15 billion. Read more here.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com

Endpoints Studio
Endpoints Webinars

Endpoints Events
Biopharma Jobs

Worldwide made. Thanks for reading.

Unsubscribe preferences

Unsubscribe from all newsletters